Characteristics | No. of patients | HO-1 expression - (%) + (%) | Pvalue |
---|---|---|---|
Tissue character | Â | Â | 0.0009*** |
 CRC | 118 | 46 (39.0) 72 (61.0) |  |
 Non-tumoral adjacent parenchyma | 37 | 26 (70.3) 11 (29.7) |  |
Sex | Â | Â | 0.586 |
 Male | 63 | 26 (41.3) 37 (58.7) |  |
 Female | 55 | 20 (36.4) 35 (63.6) |  |
Depth of wall invasion | Â | Â | 0.441 |
 T1/T2 | 24 | 11 (45.8) 13 (54.2) |  |
 T3/T4 | 94 | 35 (37.2) 59 (62.8) |  |
Differentiation | Â | Â | 0.011* |
 Well differentiated | 81 | 15 (18.5) 66 (81.5) |  |
 Poorly/moderately differentiated | 37 | 15 (40.5) 22 (59.5) |  |
Lymph node metastasis | Â | Â | 0.079 |
 Negative | 75 | 26 (34.7) 49 (65.3) |  |
 Positive | 43 | 22 (51.2) 21 (48.8) |  |
Liver metastasis | Â | Â | 0.56 |
 Negative | 114 | 45 (39.5) 69 (60.5) |  |
 Positive | 4 | 1 (25) 3 (75) |  |
TNM stages | Â | Â | 0.281 |
 I | 18 | 6 (33.3) 12 (66.7) |  |
 II | 54 | 24 (44.4) 30 (55.6) |  |
 III | 40 | 21 (52.5) 19 (47.5) |  |
 IV | 6 | 1 (16.7) 5 (83.3) |  |